Single Infusion of Gene-Editing Therapy VERVE-102 Shows Promise for Inherited High Cholesterol

Treatment Imperial patients among first in world to receive pioneering gene-editing treatment for high cholesterol

Changing one's genes; children's bleeding disorders; a specific type of high blood pressure: Upstate Medical University's HealthLink on Air for Sunday, Sept. 8, 2019

Medical oncologist Gloria Morris, MD, PhD, and nurse Rachael Grosvenor discuss the gene editing technique known as CRISPR Medical oncologist

First In-Vivo Gene-Editing Therapy Successfully Saves Newborn's Life in 2025

With grim prognosis hanging overhead, doctors and scientists at universities and institutions across the U.S. worked tirelessly to develop t

Rewriting genetic medicine

Scribe Therapeutics will soon begin clinical trials for its epigenetic treatment to tackle ‘bad’ cholesterol

Intellia Therapeutics Aktie: Lonvo-z startet FDA-Verfahren

Intellia Therapeutics erlebt turbulente Tage an der Börse. Während die Forschungserfolge der CRISPR-Spezialisten eigentlich Hoffnung machen,

A look at CRISPR and the future of gene editing

Nurse Rachael Grosvenor, left, and Nurse Rachael Grosvenor, left, and Gloria Morris, MD, PhD Gloria Morris, MD, PhD (photo by Jim Howe) (pho